Ownership and insider activity for DaVita Inc. (DVA): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes.
Price
| Price | $187.50 (closing price, October 30, 2026) |
| Market Cap | $11.8B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-22 | Maughan David Paul | F-InKind | 7,501 | $1.4M |
| 2026-08-15 | Hollar Jason M. | A-Award | 278 | |
| 2026-08-15 | DESOER BARBARA J | A-Award | 278 | |
| 2026-08-15 | Schechter Adam H | A-Award | 278 | |
| 2026-08-15 | Moore Gregory J. | A-Award | 278 | |
| 2026-08-15 | Pullin Dennis W | A-Award | 278 | |
| 2026-08-15 | Schoppert Wendy Lee | A-Award | 278 | |
| 2026-08-15 | Arway Pamela M | A-Award | 278 | |
| 2026-08-15 | YALE PHYLLIS R | A-Award | 278 | |
| 2026-07-31 | BERKSHIRE HATHAWAY INC | S-Sale | 182,980 | $36.5M |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $674.8M | $508.2M | $323.0M | $1.10B | $325.0M | $461.9M | $244.1M | $380.1M | $794.9M | $757.7M |
| Short-term Investments | $310.2M | $43.5M | $2.9M | $11.6M | $20.1M | $22.3M | $77.7M | $11.6M | $51.1M | $24.3M |
| Receivables | $1.79B | $2.16B | $2.40B | $2.31B | $2.44B | $2.41B | $2.55B | $2.42B | $2.56B | $2.96B |
| Inventory | $164.9M | $181.8M | $107.4M | $97.9M | $111.6M | $107.4M | $109.1M | $143.1M | $134.6M | $160.6M |
| Total Current Assets | $3.98B | $8.74B | $8.42B | $3.69B | $3.15B | $3.17B | $3.16B | $3.14B | $3.75B | $4.06B |
| Property, Plant & Equipment | $3.18B | $3.15B | $3.39B | $6.30B | $6.38B | $6.30B | $5.92B | $5.57B | $5.33B | $5.21B |
| Goodwill | $9.41B | $6.61B | $6.84B | $6.79B | $6.92B | $7.05B | $7.08B | $7.11B | $7.38B | $7.55B |
| Intangible Assets | $1.53B | $113.8M | $118.8M | $135.7M | $166.6M | $177.7M | $182.7M | $203.2M | $197.4M | $222.1M |
| Total Assets | $18.74B | $18.95B | $19.11B | $17.31B | $16.99B | $17.12B | $16.93B | $16.89B | $17.29B | $17.48B |
| Accounts Payable | $456.6M | $509.1M | $463.3M | $403.8M | $434.3M | $402.0M | $479.8M | $514.5M | $547.2M | $696.1M |
| Short-term Debt | $160.3M | $178.2M | $1.93B | $130.7M | $168.5M | $179.0M | $231.4M | $123.3M | $270.9M | $109.2M |
| Total Current Liabilities | $2.70B | $3.04B | $4.89B | $2.37B | $2.48B | $2.40B | $2.62B | $2.64B | $2.97B | $3.14B |
| Long-term Debt | $8.94B | $9.16B | $8.17B | $7.98B | $7.92B | $8.73B | $8.69B | $8.27B | $9.18B | $12.34B |
| Total Liabilities | $12.93B | $13.08B | $14.08B | $13.81B | $14.09B | $14.75B | $14.70B | $14.15B | $15.19B | $16.32B |
| Retained Earnings | $3.71B | $3.63B | $2.74B | $1.43B | $852.5M | $354.3M | $174.5M | $598.3M | $1.53B | -$328.4M |
| Total Equity | $4.65B | $4.69B | $3.70B | $2.13B | $1.38B | $755.5M | $712.3M | $1.06B | $121.1M | -$651.1M |
| Total Debt | $9.11B | $9.34B | $10.10B | $11.18B | $11.19B | $11.98B | $11.82B | $11.12B | $12.07B | $15.05B |
| Net Debt | $8.13B | $8.80B | $9.78B | $10.06B | $10.85B | $11.49B | $11.50B | $10.72B | $11.22B | $14.27B |
| Working Capital | $1.28B | $5.70B | $3.53B | $1.32B | $672.6M | $769.2M | $535.5M | $495.7M | $772.7M | $916.4M |
Financial Health
| Debt / Equity | -22.66 |
| Current Ratio | 1.41 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 1.56 |
Profitability
| Return on Equity | -133.21% |
| Return on Invested Capital | 10.69% |
| Return on Assets | 5.16% |
| Gross Margin | 30.96% |
| Operating Margin | 14.84% |
| Net Margin | 6.49% |
Related companies: FMS · BAX · HCA · 0J1R.L · 0RPS.L · THC · EHC · 0I7E.L
Explore sector: Healthcare · Medical - Care Facilities
More sections of DVA: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks